The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit

Free Radical Biology and Medicine

Volumn 38, Issue 9, 2005, Pages 1206-1211

  Minqin, Ren ^a   Rajendran, Reshmi ^a   Pan, Ning ^a   Tan, Benny Kwong Huat ^a   Ong, Wei Yi ^a   Watt, Frank ^a   Halliwell, Barry ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Free radicals

Indexed keywords

CHOLESTEROL; DEFEROXAMINE MESYLATE; IRON; IRON CHELATING AGENT; SODIUM CHLORIDE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL INTAKE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRY WEIGHT; IRON BLOOD LEVEL; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SCANNING TUNNELING MICROSCOPY; SPECTROSCOPY; TISSUE LEVEL; TREATMENT OUTCOME; X RAY;

EID: 15944403231     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.01.008     Document Type: Article

References (16)

1. J.T. Salonen, K. Nyyssonen, and H. Korpela High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men Circulation 86 1992 803 811
2. W.H. Giles, R.F. Anda, D.F. Williamson, R. Yip, and J. Marks Iron and ischemic heart disease Circulation 87 1993 2065 2066
3. A.J. Matthews, G.M. Vercellotti, and H.J. Menchaca Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1) J. Surg. Res. 73 1997 35 40
4. B.A. Nassar, E.M. Zayed, and L.M. Title Relation of HFE gene mutations, high iron stores and early onset coronary heart disease Can. J. Cardiol. 14 1998 215 220
5. N. Stadler, R.A. Lindner, and M.J. Davies Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper Arterioscler. Thromb. Vasc. Biol. 24 2004 949 954
6. J.L. Sullivan Iron and the sex difference in heart disease risk Lancet 1 1981 1293 1294
7. D. Ponraj, J. Makjanic, P.S.P. Thong, B.K.H. Tan, and F. Watt The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion FEBS Lett. 459 1999 218 222
8. T.S. Lee, M.S. Shiao, and C.C. Pan Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice Circulation 99 1999 1222 1229
9. E.D. Wills Lipid peroxide formation of microsomes: the role of non-haem iron Biochem. J. 113 1969 325 332
10. J.M.C. Gutteridge, R. Richmond, and B. Halliwell Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine Biochem. J. 184 1979 469 472
11. B. Halliwell Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic Biol. Med. 7 1989 645 651
12. M.Q. Ren, F. Watt, B.K.H. Tan, and B. Halliwell Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions Free Radic. Biol. Med. 34 2003 746 752
13. M.C. Gutteridge, and R.M. Tyrrell A novel iron chelator that does not induce HIF-1 activity Free Radic. Biol. Med. 33 2002 356 363
14. S.J. Duffy, E.S. Biegelsen, and M. Holbrook Iron chelation improves endothelial function in patients with coronary artery disease Circulation 103 2001 2799 2804
15. V. Chekanov, M. Maternowski, and V. Nikolaychik Pharmacological support of angiogenesis using deferoxamine in biological glue for cardiomyoplasty Basic Appl. Myol. 10 2000 61 62
16. B. Halliwell Superoxide, iron, vascular endothelium and reperfusion injury Free Radic. Res. Commun. 5 1989 315 318